NYSE - Delayed Quote • USD
Koninklijke Philips N.V. (PHG)
At close: 4:00 PM EDT
After hours: 4:09 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 8 | 8 |
| Avg. Estimate | 0.28 | 0.33 | 1.43 | 1.68 |
| Low Estimate | 0.28 | 0.33 | 0.87 | 1.21 |
| High Estimate | 0.28 | 0.33 | 1.6 | 1.94 |
| Year Ago EPS | -- | 0.3 | 1.33 | 1.43 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 9 | 9 |
| Avg. Estimate | 4.45B | 4.79B | 20.05B | 21.03B |
| Low Estimate | 4.45B | 4.79B | 19.77B | 20.64B |
| High Estimate | 4.45B | 4.79B | 20.81B | 21.88B |
| Year Ago Sales | -- | -- | 19.38B | 20.05B |
| Sales Growth (year/est) | -- | -- | 3.40% | 4.90% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | |
|---|---|---|---|---|
| EPS Est. | -- | 0.31 | 0.35 | 0.6 |
| EPS Actual | -- | 0.3 | 0.36 | 0.44 |
| Difference | -- | -0.01 | 0.01 | -0.16 |
| Surprise % | -- | -3.20% | 2.90% | -26.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.28 | 0.33 | 1.43 | 1.68 |
| 7 Days Ago | 0.28 | 0.33 | 1.44 | 1.69 |
| 30 Days Ago | 0.3 | 0.34 | 1.49 | 1.76 |
| 60 Days Ago | 0.3 | 0.33 | 1.49 | 1.76 |
| 90 Days Ago | 0.34 | 0.37 | 1.62 | 1.9 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | PHG | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.60% |
| Next Qtr. | 10.00% | -- | -- | 10.50% |
| Current Year | 7.50% | -- | -- | 5.20% |
| Next Year | 17.50% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 16.60% | -- | -- | 11.22% |
| Past 5 Years (per annum) | 11.31% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Downgrade | Societe Generale: Buy to Hold | 7/25/2022 |
| Downgrade | Jefferies: Buy to Hold | 1/20/2022 |
| Upgrade | HSBC: Hold to Buy | 1/14/2022 |
| Downgrade | Citigroup: Buy to Neutral | 1/12/2022 |
| Downgrade | Deutsche Bank: Buy to Hold | 7/8/2021 |
| Upgrade | JP Morgan: Neutral to Overweight | 3/18/2021 |
Related Tickers
SNN Smith & Nephew plc
23.84
-0.71%
BSX Boston Scientific Corporation
67.33
-0.13%
IART Integra LifeSciences Holdings Corporation
28.68
-9.33%
ATEC Alphatec Holdings, Inc.
12.54
+1.62%
STE STERIS plc
199.51
-0.65%
CNMD CONMED Corporation
72.64
+2.19%
PODD Insulet Corporation
166.25
+0.92%
MDT Medtronic plc
79.48
+0.37%
NVRO Nevro Corp.
12.07
-2.03%
INGN Inogen, Inc.
6.75
-4.80%